Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway

被引:42
作者
Li, Hui [1 ]
Zhang, Yu [1 ]
Hai, Jun [1 ]
Wang, Jixin [2 ]
Zhao, Bei [3 ]
Du, Lixue [1 ]
Geng, Xilin [1 ]
机构
[1] Shaanxi Prov Peoples Hosp, Hepatobiliary Surg, 256 Youyi West Rd, Xian 710068, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 2, Gen Surg, Xian 710004, Shaanxi, Peoples R China
[3] Shaanxi Prov Peoples Hosp, Hlth Insurance & Rural Cooperat Med Serv Manageme, Xian 710068, Shaanxi, Peoples R China
关键词
TRIM31; Proliferation; Invasion; Gallbladder cancer; MMP2/9; CARCINOMA; GROWTH;
D O I
10.1016/j.biopha.2018.04.120
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tripartite motif (TRIM) 31, a member of the TRIM protein family, contributes to a wide range of biological processes and its altered expression exerts a non-negligible effect on multiple pathological conditions such as immunological disorders and retroviral protective activity. Recently, increasing evidence has demonstrated an important role of TRIM31 in the development of various cancers. However, the role of TRIM31 in gallbladder cancer (GBC) remains unclear. In this study, we showed that TRIM31 was elevated in GBC tissues and cell lines and associated with the clinicopathological features of GBC patients. Down-regulation of TRIM31 suppressed GBC cell proliferation, migration and invasion in vitro as well as inhibited tumor growth and metastasis in vivo. In addition, knockdown of TRIM31 reduced the expression of MMP2, MMP9 and p-Akt. Taken together, these findings indicated that knockdown of TRIM31 suppressed proliferation and invasion of GBC cells and was associated with PI3K/Akt signaling inactivation. Thus, TRIM31 may be a potential therapeutic target for the treatment of GBC.
引用
收藏
页码:1272 / 1278
页数:7
相关论文
共 34 条
[1]  
[Anonymous], 2017, ONCOGENE, DOI DOI 10.1038/0NC.2017.349
[2]  
[Anonymous], EVIDENCE BASED COMPL
[3]  
[Anonymous], 2023, CA Cancer J Clin, DOI DOI 10.3322/caac.21772
[4]   Long-term results after resection for gallbladder cancer - Implications for staging and management [J].
Bartlett, DL ;
Fong, YM ;
Fortner, JG ;
Brennan, MF ;
Blumgart, LH .
ANNALS OF SURGERY, 1996, 224 (05) :639-646
[5]   TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein [J].
Bhatnagar, Sanchita ;
Gazin, Claude ;
Chamberlain, Lynn ;
Ou, Jianhong ;
Zhu, Xiaochun ;
Tushir, Jogender S. ;
Virbasius, Ching-Man ;
Lin, Ling ;
Zhu, Lihua J. ;
Wajapeyee, Narendra ;
Green, Michael R. .
NATURE, 2014, 516 (7529) :116-U313
[6]   Gallbladder cancer: Past, present and an uncertain future [J].
Boutros, C. ;
Gary, M. ;
Baldwin, K. ;
Somasundar, P. .
SURGICAL ONCOLOGY-OXFORD, 2012, 21 (04) :E183-E191
[7]  
Cai Q, 2016, AM J TRANSL RES, V8, P4068
[8]   Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer [J].
Cao, Yang ;
Liu, Xiyong ;
Lu, Wei ;
Chen, Yuanyuan ;
Wu, Xiangsong ;
Li, Maolan ;
Wang, Xu-An ;
Zhang, Fei ;
Jiang, Lin ;
Zhang, Yijian ;
Hu, Yunping ;
Xiang, Shanshan ;
Shu, Yijun ;
Bao, Runfa ;
Li, Huaifeng ;
Wu, Wenguang ;
Weng, Hao ;
Yen, Yun ;
Liu, Yingbin .
CANCER LETTERS, 2015, 360 (02) :141-150
[9]   The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications [J].
Carnero, Amancio ;
Blanco-Aparicio, Carmen ;
Renner, Oliver ;
Link, Wolfgang ;
Leal, Juan F. M. .
CURRENT CANCER DRUG TARGETS, 2008, 8 (03) :187-198
[10]   Tripartite Motif Containing 28 (Trim28) Can Regulate Cell Proliferation by Bridging HDAC1/E2F Interactions [J].
Chen, Lu ;
Chen, Dung-Tsa ;
Kurtyka, Courtney ;
Rawal, Bhupendra ;
Fulp, William J. ;
Haura, Eric B. ;
Cress, W. Douglas .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (48) :40106-40118